First Wave BioPharma, Inc. (FWBI)
NASDAQ: FWBI · IEX Real-Time Price · USD
2.740
+0.010 (0.37%)
At close: Apr 26, 2024, 4:00 PM
2.820
+0.080 (2.92%)
After-hours: Apr 26, 2024, 5:37 PM EDT

First Wave BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014
Market Capitalization
635182927204246--
Market Cap Growth
--44.13%-71.82%-38.96%8.45%32.70%-51.23%-7.94%---
Enterprise Value
3-0511242920424461
PE Ratio
-0.18-0.18-0.34-0.21-0.71-1.79-1.51-3.79-3.13--
PB Ratio
1.540.791.85-2.30-11.175.894.5825.3114.21--
P/FCF Ratio
-0.23-0.23-0.23-0.56-2.65-1.93-1.88-5.82-10.04--
P/OCF Ratio
-0.23-0.23-0.23-0.56-2.63-1.94-1.89-5.85-10.07--
EV/EBITDA Ratio
0.010.01-0.31-0.19-0.91-2.08-1.55-4.42-5.56-1.64-0.43
EV/EBIT Ratio
0.010.01-0.31-0.18-0.89-1.93-1.46-4.09-5.08-1.36-0.35
EV/FCF Ratio
0.010.01-0.20-0.33-2.15-2.03-1.79-5.80-9.68-1.41-0.68
Debt / Equity Ratio
0.230.230.32-0.13-0.210.330.060.250.05-1.810.40
Debt / EBITDA Ratio
-0.05-0.05-0.06-0.02-0.02-0.11-0.02-0.04-0.02-1.82-0.56
Debt / FCF Ratio
-0.07-0.07-0.04-0.03-0.05-0.11-0.02-0.06-0.03-1.57-0.88
Quick Ratio
1.201.200.600.670.430.671.450.691.180.200.28
Current Ratio
1.581.581.370.770.510.801.600.791.270.240.27
Interest Coverage
-702.16-702.16-920.32-5209.31-4.59-33.98-131.88-11.68-1.46-2.74-33.71
Return on Equity (ROE)
-614.80%-614.80%260.80%-5086.10%-1221.30%-450.40%-289.00%-419.90%7001.30%1204.20%-
Return on Assets (ROA)
-284.10%-284.10%-262.30%-604.00%-373.50%-164.50%-163.90%-167.50%-217.10%-89.40%-
Return on Capital (ROIC)
-356.02%-356.02%-349.66%869.61%1265.76%-240.18%-279.59%-485.34%-196.70%-160.43%-63.00%
Earnings Yield
-290.20%-568.01%-295.07%-469.39%-141.47%-55.80%-66.02%-26.40%-31.96%--
FCF Yield
-223.06%-436.61%-440.32%-179.71%-37.74%-51.68%-53.30%-17.17%-9.96%--
Buyback Yield / Dilution
-836.57%-836.57%-1589.98%-213.88%-26.78%-45.11%-45.45%-63.23%-80.23%-2.38%-
Total Shareholder Return
-836.57%-836.57%-1589.98%-213.88%-26.78%-45.11%-45.45%-63.23%-80.23%-2.38%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).